Quaker Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$82.3K Hold
353
– – 0.02% 133
2026
Q2
$74.8K Sell
353
-2
-0.6% -$393 0.02% 137
2026
Q1
$69.6K Buy
355
+2
+0.6% +$389 0.02% 134
2025
Q4
$61.3K Hold
353
– – 0.02% 147
2025
Q3
$67.3K Buy
353
+2
+0.6% +$355 0.02% 138
2025
Q2
$63.1K Buy
+351
New +$61K 0.02% 145

Other funds holding DGX

Quaker Wealth Management's DGX Position: Q3 2026 in Review

Quaker Wealth Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 353 shares worth $82.3K. The position accounts for 0.02% of the portfolio, ranked #133.

Quaker Wealth Management first reported a position in DGX in Q2 2025 and has held it in 6 quarters since. 661 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Quaker Wealth Management held 353 shares of Quest Diagnostics worth $82.3K as of Q3 2026.
  • Quaker Wealth Management left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.02% of Quaker Wealth Management's portfolio in Q3 2026, its #133 holding.
  • Quaker Wealth Management first reported a position in Quest Diagnostics in Q2 2025 and has held it in 6 quarters since.
  • 661 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.